Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2002
04/04/2002WO2002026998A2 Hydrolases
04/04/2002WO2002026997A2 Dsp-16 dual-specificity phosphatase
04/04/2002WO2002026996A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
04/04/2002WO2002026988A2 Human drug metabolizing enzymes
04/04/2002WO2002026987A2 A human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine
04/04/2002WO2002026985A2 G-protein coupled recptors
04/04/2002WO2002026984A2 Potassium channel interactors and uses therefor
04/04/2002WO2002026982A2 Secreted human proteins
04/04/2002WO2002026981A2 Human protease inhibitor proteins and polynucleotides encoding the same
04/04/2002WO2002026980A2 Human ion-exchanger proteins and polynucleotides encoding t he same
04/04/2002WO2002026979A1 NOVEL ENZYME HAVING β-GLUCOSIDASE ACTIVITY AND USE THEREOF
04/04/2002WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
04/04/2002WO2002026975A1 Novel polypeptide- human rhombus related protein 48-35.53 and polynucleotide encoding it
04/04/2002WO2002026974A1 A novel polypeptide- transcription factor xap-2 protein 49.72 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026973A1 A novel polypeptide-human heterogeneous nuclear ribonucleoprotein 32.01 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026971A1 A novel polypeptide- human transcription factor lcr-f112.1 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026970A1 A novel polypeptide- human neural cell adhesion molecule 11.44 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026968A2 Antisense iap nucleic acids and uses thereof
04/04/2002WO2002026965A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
04/04/2002WO2002026963A1 Shingolipid ceramide deacylase gene
04/04/2002WO2002026958A2 Human neprilysin protease
04/04/2002WO2002026955A2 Human proteases and polynucleotides encoding the same
04/04/2002WO2002026953A1 A novel peptide human vacuolar h+-atpase 36.08 and the polynucleotide coding this novel polypeptide
04/04/2002WO2002026952A1 A novel peptide---human serine/threonine protein kinase 11.22 and the polynucleotide coding this novel peptide
04/04/2002WO2002026951A2 Oxidoreductases
04/04/2002WO2002026950A2 Transferases
04/04/2002WO2002026949A2 Human proteases and polynucleotides encoding the same
04/04/2002WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
04/04/2002WO2002026940A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells
04/04/2002WO2002026937A1 Chemical substance for protection of brain nerve cell and method for producing thereof
04/04/2002WO2002026936A2 Gene expression in the central nervous system regulated by neuroleptic agents
04/04/2002WO2002026935A2 TGF-β INHIBITORS AND METHODS
04/04/2002WO2002026932A2 Rna aptamers and methods for identifying the same
04/04/2002WO2002026931A2 71 human secreted proteins
04/04/2002WO2002026828A1 A novel peptide-human class iii mhc 61 and the polynucleotide coding this novel peptide
04/04/2002WO2002026827A1 Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules
04/04/2002WO2002026826A2 Proteins and nucleic acids encoding same
04/04/2002WO2002026825A2 G-protein coupled receptors
04/04/2002WO2002026824A2 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues
04/04/2002WO2002026823A2 A novel human g-protein coupled receptor, hgprbmy7, expressed highly in spinal cord
04/04/2002WO2002026822A2 Pumpcn compositions and uses thereof
04/04/2002WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus
04/04/2002WO2002026818A2 Human nedd-1
04/04/2002WO2002026817A2 33521, a human guanine nucleotide exchange family member and uses thereof
04/04/2002WO2002026814A1 A novel peptide---human protein 8.8 including 4 peptide repeat sequences and the polynucleotide coding this novel peptide
04/04/2002WO2002026813A1 A novel peptide - human muscle cell enhanced associative factor 222.88 and the polynucleotide coding this novel peptide
04/04/2002WO2002026812A1 A novel peptide---human dna cgg repeated associative protein 16.17 and the polynucleotide coding this novel peptide
04/04/2002WO2002026811A1 A novel peptide---symplekin 8,91 and the polynucleotide coding this novel peptide
04/04/2002WO2002026809A1 A new polypeptide- transmembrane 35.31 containing epidermal growth factor-like repeating domain and the polynucleotide encoding it
04/04/2002WO2002026808A1 A novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same
04/04/2002WO2002026807A1 A novel peptide---human krupple zinc finger related protein 70.84 and the polynucleotide coding this novel peptide
04/04/2002WO2002026806A1 A novel peptide-human myosin heavy chain b22.22 and the polynucleotide coding this novel peptide
04/04/2002WO2002026802A2 M32404, a novel human trypsin and uses thereof
04/04/2002WO2002026799A1 A novel polypeptide -human cytoplasmic dynein intermediated chain (ic) 9.35 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026798A1 A novel polypeptide -phosphatidic acid phosphatase 29.81 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026797A1 A novel polypeptide -human dehydrogenase 29.15 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026796A1 A novel polypeptide human growth factor receptor 14.3 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026795A1 A novel polypeptide, a human dihydroorotase 15.29 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026794A1 A novel polypeptide, a human ribosomal protein l7a20.57 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026793A1 A novel polypeptide-homo macro-protein 62 and polynucleotide encoding said polypeptide
04/04/2002WO2002026792A1 A novel polypeptide, a human big protein 9.24 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026791A1 A novel polypeptide-sr protein specificity serine kinase 212.98 and polynucleotide encoding said polypeptide
04/04/2002WO2002026790A1 A novel polypeptide-homo tnfr/ngfr protein 9.02 containing cytochrome c structural domain and polynucleotide encoding said polypeptide
04/04/2002WO2002026785A2 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
04/04/2002WO2002026784A2 Matrix proteins m1 and m2 of infections salmon anaemia virus
04/04/2002WO2002026782A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
04/04/2002WO2002026781A2 Ige receptor antagonists
04/04/2002WO2002026780A2 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
04/04/2002WO2002026779A2 A fibrin/fibrinogen-binding conjugate
04/04/2002WO2002026778A2 Isolated peptides which bind to hla-c molecules and uses thereof
04/04/2002WO2002026777A1 Peptide ligands for prostate specific antigen
04/04/2002WO2002026776A2 Peptide-based compounds
04/04/2002WO2002026775A2 Compositions and methods for regulating apoptosis
04/04/2002WO2002026774A2 Melanocortin receptor ligands
04/04/2002WO2002026758A1 Oligonucleotide modulation of her-1 expression
04/04/2002WO2002026566A2 Container tracking system
04/04/2002WO2002026325A2 Restoration of perturbed barrier function by application of antiandrogens
04/04/2002WO2002026259A1 A pharmaceutical composition for treating acids and its preparation
04/04/2002WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
04/04/2002WO2002026257A1 Antibodies to the propeptide of candida albicans and methods of use
04/04/2002WO2002026249A2 Methods for inhibition of viral infection
04/04/2002WO2002026248A1 Stable peptide formulations
04/04/2002WO2002026247A2 Ixodes salivary anticomplement protein
04/04/2002WO2002026246A2 Pharmaceutical compositions comprising polynucleotides encoding a raf protein
04/04/2002WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
04/04/2002WO2002026243A1 Composition for diminishing neutral fat in blood
04/04/2002WO2002026241A1 Polymeric micelle containing cisplatin enclosed therein and use thereof
04/04/2002WO2002026215A2 Thermogelling biodegradable aqueous polymer solution
04/04/2002WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids
04/04/2002WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/04/2002WO2002010339A3 Gene expression profile for kshv infection and methods for treating same
04/04/2002WO2002008435A8 Codon-optimized papilloma virus sequences
04/04/2002WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS
04/04/2002WO2002004012A8 Anhydrous pharmaceutical composition of vancomycin for topical use
04/04/2002WO2002003961B1 Microspheres and adjuvants for dna vaccine delivery
04/04/2002WO2001098487A8 Polynucleotides and polypeptides linked to blood pressure regulation and/or fatigue
04/04/2002WO2001098467A3 Regulation of human prostasin-like serine protease
04/04/2002WO2001098327A3 Glycopeptide carboxy-saccharide derivatives
04/04/2002WO2001097771A3 Preparations that contain an extract of the plant pistia stratiotes
04/04/2002WO2001093893A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy